Topical products: Aiming for quality, simplicity, and cost-efficiency in their development, scale-up, and manufacturing
Pharmaceutical Technology
JANUARY 6, 2023
It is important for a CDMO to understand the market it serves and, in the dermatologic arena, that means the demand for topical agents across a broad array of indications. In vitro release testing to demonstrate bioequivalence. Products must also be tested for bioburden to demonstrate that they do not harbour microbial contaminants.
Let's personalize your content